RESEARCH TRIANGLE PARK, N.C., May 23 /PRNewswire-FirstCall/ -- Icoria,
Inc. (Nasdaq: ICOR) announced today that Chief Scientific Officer and Vice
President, Research, Thomas J. Colatsky, Ph.D., will provide an overview of
the Company at the upcoming Fourth Annual Needham & Company Biotechnology
Conference at The New York Palace Hotel on Wednesday, May 25th at 4:30 PM ET.
About Icoria
Icoria, Inc. is a biotechnology company focused on the discovery of novel,
multi-parameter biomarkers using its unique multi-platform approach. Icoria
hopes to use these future biomarkers internally to develop multi-analyte
diagnostics to define and grade pathology or disease state with a high level
of specificity and sensitivity. Icoria also intends to use its technology to
help its collaborators and customers develop better, safer drugs and
diagnostics and to identify targets, leads and drug/diagnostic combinations
for liver injury, metabolic disorders and cancer.
This press release contains forward-looking statements including, but not
limited to, the Company's expectations for its healthcare based business model
and its biomarker discovery platform. Such forward-looking statements are
based on management's current expectations and are subject to a number of
risks, factors and uncertainties that may cause actual results, events and
performance to differ materially from those referred to in the forward-looking
statements. These risks, factors and uncertainties include, but are not
limited to, Icoria's ability to identify biomarkers, early stage of
development, history of net losses, technological and product development
uncertainties, reliance on research collaborations, uncertainty of additional
funding and ability to protect its patents and proprietary rights. Certain of
these and other risks are identified in Icoria's Quarterly Report on Form 10-Q
for the period ended March 31, 2005, as amended, and its Annual Report on Form
10-K for the year ended December 31, 2004, both as filed with the Securities
and Exchange Commission. The Company does not intend to update any of the
forward-looking statements after the date of this release to conform these
statements to actual results or to changes in our expectations, except as may
be required by law.
SOURCE Icoria, Inc.
 back to top
Related links:
http://www.icoria.com
CONTACT:
Media/Public Relations: Icoria, Inc.,
+1-919-425-2999; or Brian Ritchie of Noonan Russo,
+1-212-845-4200
|
